<?xml version="1.0" encoding="UTF-8"?>
<p>The programme initially focused on increasing access to affordable diagnostics; providing free DAA treatment to persons with severe liver disease at highest‐risk of hepatitis C‐related mortality; and building capacity to achieve programme goals of preventing transmission and eliminating the disease.
 <xref rid="liv14222-bib-0039" ref-type="ref">39</xref> Initial obstacles included suboptimal alignment of programme development and implementation, leading to bottlenecks in patient flow and wait lists.
 <xref rid="liv14222-bib-0040" ref-type="ref">40</xref> Training for healthcare workers was only provided after the programme launched; however, doctors have subsequently received continuous technical support.
</p>
